Fundraising

Monogram Capital Partners II's launch comes as the fundraising market is being battered by the covid-19 pandemic, creating fresh challenges for first- and second-time vehicles.

Our survey sheds light on how sponsors expect coronavirus to affect their plans in the near term, including fundraising, new investments and portfolio company layoffs.

Riverwood’s fundraising milestone follows an expansion of the firm's partners to eight with the January promotions of Harish Belur, Joaquim Lima and Scott Ransenberg.

Total private equity capital raised in the period is the second-highest in first quarter fundraising since 2015.

The fund hit the market in January so it already built up momentum prior to fundraising slowing in the coronavirus-fueled downturn.

Investors backed American Pacific Group’s first offering, founder and managing partner Fraser Preston said, because of its niche focus on lower mid-market companies “the market has passed over.”

Firms that had already been raising for months before the downturn, even emerging managers, could still hit their targets as long as they are most of the way there.

Experts from law firm Dechert outline ways GPs can raise additional capital for the portfolios.

The firm has yet to make any investments from fund V, which exceeded its fundraising target by $500m.

The general expectation is that strong GPs who were already raising should be able to hit targets, but funds just coming to market, especially from newer firms, could have problems.